Form D · Other
Smith Health, Inc.
San Francisco, CA · CIK 0001921816
Offering snapshot reported Feb 15, 2024 · SEC filing
- Reported sold
- $60M Offering amount: $60M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 15, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 15, 2024 | Initial | $59,999,968 | No comparison | 9 | SEC filing |
| Apr 6, 2022 | Initial | $27,163,747 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505403
Amount sold does include $4,999,987.96 sold to eight investors who reside outside the United States.
Source: Form D, filed Feb 15, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jacob Frenz | Director, Executive |
| Siobhan Nolan Mangini | Director |
| Matthew Mc Knight | Director |
| Bryan Roberts | Director |
Issuer details
Industry: Other (See others in industry)
Address:
300 Brannan Street Suite 601
San Francisco, CA, 94107
San Francisco, CA, 94107